Patrick Y. Wen

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.

Susan M. Chang, M. Gilbert, M. Mehta, 2020, Neuro-oncology.

The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.

Susan M. Chang, D. Brat, J. Sarkaria, 2019, Neuro-oncology.

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

Timothy F Cloughesy, Mark R Gilbert, Patrick Y Wen, 2008, Neuro-oncology.

NABTC phase I/II trial of ZD-1839 for recurrent malignant gliomas and unresectable meningiomas.

M. Prados, F. Lieberman, P. Wen, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study.

Susan M. Chang, W. Yung, M. Prados, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism

Jessica M. Rusert, Deric M. Park, Neel S. Madhukar, 2018, Clinical Cancer Research.

PCV for anaplastic oligodendrogliomas: back to the future or a step backwards?

P. Wen, J. Villano, E. Lee, 2013, Journal of Neuro-Oncology.

Updates in the management of brain metastases.

Eudocia Q Lee, Brian M Alexander, Riccardo Soffietti, 2016, Neuro-oncology.

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE

Brian M Alexander, Mitchel S Berger, Timothy F Cloughesy, 2017, Clinical Cancer Research.

Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.

Sankha S. Basu, Susan M. Chang, W. Yung, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

W. Yung, M. Prados, M. Gilbert, 2011, Neuro-oncology.